IMCC
IM Cannabis Corp.
There isn't enough reported data to score IMCC yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
IMCC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Weak |
IMCC's revenue, profitability, cash flow and balance sheet are all currently weak.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
IMCC PE Valuation
IMCC has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
IMCC Forward outlook
There aren't enough analyst estimates for IMCC to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IMCC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2020 | -$629.57 | -$607.83 |
IMCC lost $629.57 per share over the past year, a bigger loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over IMCC in the latest year-over-year earnings comparison.
IMCC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.3M | -40% |
| Q1 2026 | $6.1M | -31% |
| Q4 2025 | $7.9M | -16% |
| Q3 2025 | $9.7M | -0.2% |
| Q2 2025 | $8.9M | -14% |
| Q1 2025 | $8.8M | +3.6% |
| Q4 2024 | $9.4M | +25% |
| Q3 2024 | $9.8M | +12% |
IMCC's revenue has slid since its 2024 peak: $5M last quarter, down 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | -25 points |
| Q1 2026 | -19% | -21 points |
| Q4 2025 | -25% | +123 points |
| Q3 2025 | -30% | -37 points |
| Q2 2025 | -2.8% | -22 points |
| Q1 2025 | 1.3% | +48 points |
| Q4 2024 | -148% | -99 points |
| Q3 2024 | 6.9% | -11 points |
IMCC's operating margin was −28% last quarter, down 25 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over IMCC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over IMCC on profitability, with a higher operating margin.
IMCC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$927.5K | -$610.6K |
| Q1 2026 | -$134.3K | -104% |
| Q4 2025 | $1.9M | +$4.8M |
| Q3 2025 | -$2.5M | -231% |
| Q2 2025 | -$317K | -234% |
| Q1 2025 | $3.1M | +$3.6M |
| Q4 2024 | -$3M | -$2.8M |
| Q3 2024 | $1.9M | -50% |
IMCC has burned cash in most quarters: −$2M over the past year, against $2M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over IMCC on cash generation, producing positive trailing cash flow while its opponent burns cash.
IMCC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | 14.0x | High |
| Q4 2023 | 26.3x | High |
IMCC's net debt is about 14 years of its operating earnings (EBITDA).
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
IMCC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.7 | Oversold |
| Stochastic | 0.6 | Oversold |
IMCC's weekly RSI is 29 (oversold) and its Stochastic is 1 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
IMCC PE vs Healthcare Sector
IMCC has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
IMCC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.34 | 59% below |
| 20 week MA | $2.68 | 79% below |
| 50 week MA | $15.3 | 96% below |
| 100 week MA | $40.2 | 99% below |
| 200 week MA | $75.3 | 99% below |
IMCC is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over IMCC on trend strength, trading above more of its moving averages.
IMCC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3,556.8 | $15,120.0 | +325% |
| 2021 | $15,120.0 | $6,516.0 | -57% |
| 2022 | $6,516.0 | $189.0 | -97% |
| 2023 | $189.0 | $64.2 | -66% |
| 2024 | $64.2 | $73.2 | +14% |
| 2025 | $73.2 | $42.9 | -41% |
| 2026 YTD | $42.9 | $0.55 | -99% |
IMCC's yearly returns have swung widely, from +325% in 2020 to −97% in 2022. It's down 99% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over IMCC on returns for 2026, with the stronger performance.